It is increasingly recognized that although clinical manifestations of many neurological disorders occur in later decades, an individual's susceptibility to disease is determined early in life. In the Framingham Heart Study, we have identified genetic, cardiovascular risk factor and biomarker data related to the subsequent development of AD in our Original Gen1, elderly cohort that are also associated with structural and cognitive endophenotypes (heritable intermediate phenotypes) in our Offspring Gen2, middle aged cohort. In the proposed MRI, Genetic, Cognitive &Biomarker Precursors of AD &Dementia in Young Adults grant we hypothesize that the structural and cognitive continuum we have observed in our younger Gen2 participants represents the lengthening of a continuum that begins even earlier in life and will be extended to this still younger Gen3 cohort. Gen 3 represents a richly characterized group of young-adults in whom dense genotyping, comprehensive biomarker and abundant vascular risk factor, documented family occurrence of disease such as AD and dementia, and subclinical atherosclerosis data are available. Our primary goal is to characterize brain morphology on MRI and cognitive function in the Gen3 cohort, specifically previously identified endophenotypes of AD and dementia (such as total and regional brain volumes, white matter lesions, and regional quantitative measures of the hippocampal and entorhinal cortex as well as memory and executive function.) We predict within this younger Gen3 cohort there is an identifiable continuum of structural and cognitive indices linked to dementia and brain aging. We will also relate previously measured vascular, metabolic, inflammatory, family occurrence of AD/dementia and other risk factor data already available on these subjects to the range of structural and functional AD/dementia endophenotypes. We posit that a subset of the risk factors previously identified in the older Gen2 cohort will show similar associations in Gen 3. Further we anticipate uncovering additional risk factors related to AD/dementia endophenotypes unique to this younger cohort. Finally, we will utilize the extensive genetic resources currently available in all three generations of the Framingham cohorts to uncover age-specific genetic effects, gene environment interactions and novel genetic relationships. This application represents a resource-effective mechanism to leverage the wealth of genetic, risk factor and biomarker data collected in this younger adult community-based population to greatly enrich our understanding of preclinical AD and pathophysiology of disease.

Public Health Relevance

The primary objective of the proposed project, MRI, Cognitive, Genetic &Biomarker Precursors of AD &Dementia in Young Adults is to identify the earliest indicators of a propensity to develop AD and dementia in later life. To accomplish this goal we seek to establish, within the Framingham Heart Study's third generation cohort, baseline measures of brain morphology and cognitive function that have been linked to AD/dementia. We will relate these data to previously measured risk factors and biomarkers already available on these subjects to determine a """"""""pre-MCI"""""""" continuum of structural and functional indices of AD and dementia.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG033040-05
Application #
8403404
Study Section
Neurological, Aging and Musculoskeletal Epidemiology (NAME)
Program Officer
Anderson, Dallas
Project Start
2009-01-15
Project End
2014-12-31
Budget Start
2013-01-01
Budget End
2014-12-31
Support Year
5
Fiscal Year
2013
Total Cost
$889,503
Indirect Cost
$130,366
Name
Boston University
Department
Neurology
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17
Hankee, Lisa D; Preis, Sarah R; Piers, Ryan J et al. (2016) Population Normative Data for the CERAD Word List and Victoria Stroop Test in Younger- and Middle-Aged Adults: Cross-Sectional Analyses from the Framingham Heart Study. Exp Aging Res 42:315-28
Maillard, Pauline; Mitchell, Gary F; Himali, Jayandra J et al. (2016) Effects of Arterial Stiffness on Brain Integrity in Young Adults From the Framingham Heart Study. Stroke 47:1030-6
Satizabal, Claudia L; Beiser, Alexa S; Chouraki, Vincent et al. (2016) Incidence of Dementia over Three Decades in the Framingham Heart Study. N Engl J Med 374:523-32
Choi, Seung Hoan; Ruggiero, Daniela; Sorice, Rossella et al. (2016) Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies. PLoS Genet 12:e1005874
Souillard-Mandar, William; Davis, Randall; Rudin, Cynthia et al. (2016) Learning Classification Models of Cognitive Conditions from Subtle Behaviors in the Digital Clock Drawing Test. Mach Learn 102:393-441
Piers, Ryan J; Nishtala, Arvind; Preis, Sarah R et al. (2016) Association between atrial fibrillation and volumetric magnetic resonance imaging brain measures: Framingham Offspring Study. Heart Rhythm 13:2020-4
Libon, David J; Preis, Sarah R; Beiser, Alexa S et al. (2015) Verbal memory and brain aging: an exploratory analysis of the role of error responses in the Framingham Study. Am J Alzheimers Dis Other Demen 30:622-8
Weinstein, Galit; Maillard, Pauline; Himali, Jayandra J et al. (2015) Glucose indices are associated with cognitive and structural brain measures in young adults. Neurology 84:2329-37
Saber, Hamidreza; Himali, Jayandra J; Shoamanesh, Ashkan et al. (2015) Serum Leptin Levels and the Risk of Stroke: The Framingham Study. Stroke 46:2881-5

Showing the most recent 10 out of 31 publications